Dr. Na Wang | Chemotherapy | Best Researcher Award

Dr. Na Wang | Chemotherapy | Best Researcher Award

First Affiliated Hospital of Xi’an Jiaotong University | China

AUTHOR PROFILE

Scopus

📘 DR. NA WANG, DEPARTMENT OF RESPIRATORY AND CRITICAL CARE MEDICINE, FIRST AFFILIATED HOSPITAL OF XI’AN JIAOTONG UNIVERSITY

🏫 EARLY ACADEMIC PURSUITS

Dr. Na Wang embarked on a distinguished academic journey, laying a strong foundation in respiratory medicine and critical care. She pursued her medical degree with a focus on respiratory health, demonstrating exceptional dedication and a commitment to addressing complex medical challenges. Her postgraduate studies were marked by advanced training in pulmonology, where she honed her expertise in the diagnosis and management of respiratory diseases.


🏥 PROFESSIONAL ENDEAVORS

Currently serving at the First Affiliated Hospital of Xi’an Jiaotong University, Dr. Wang plays a pivotal role in the Department of Respiratory and Critical Care Medicine. She has contributed significantly to clinical care, focusing on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and the broader spectrum of critical care management. Dr. Wang is recognized for her ability to translate complex clinical scenarios into innovative therapeutic strategies, improving patient outcomes.


🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Dr. Wang’s research is centered on Chronic Obstructive Pulmonary Disease (COPD), particularly its acute exacerbations, which are leading causes of hospitalization and mortality worldwide. Her studies delve into:

  • The pathophysiological mechanisms underlying AECOPD.
  • Biomarker identification for early diagnosis and prognosis.
  • Innovative therapeutic approaches, including pharmacological and non-pharmacological strategies.
    Her work bridges clinical insights with translational research, contributing to the development of effective treatment modalities.

🌟 IMPACT AND INFLUENCE

Dr. Wang’s research has had a profound impact on the respiratory medicine field, especially in China. Her findings have been instrumental in shaping clinical guidelines for AECOPD management, benefiting countless patients. She is a sought-after speaker at national and international conferences, sharing her expertise on managing critical respiratory conditions.


📚 ACADEMIC CITES

With a growing body of published works, Dr. Wang has contributed extensively to peer-reviewed journals. Her articles are widely cited, reflecting the significance of her research. She continues to advance the field through collaborations with leading respiratory medicine experts and research teams globally.


🌏 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Na Wang is poised to leave an enduring legacy in respiratory and critical care medicine. Her commitment to:

  1. Advancing knowledge in AECOPD management.
  2. Mentoring future clinicians and researchers.
  3. Pioneering innovative therapeutic approaches.
    ensures that her influence will resonate for years to come. Her future contributions are expected to address emerging challenges in respiratory health and critical care, particularly in aging populations.

🛠 OTHER IMPORTANT TOPICS

💡 MULTIDISCIPLINARY APPROACH

Dr. Wang advocates for collaboration across specialties to improve patient care and advance research. Her work integrates insights from immunology, pharmacology, and critical care practices.


🎓 EDUCATION AND TRAINING INITIATIVES

Dr. Wang is actively involved in teaching and training, emphasizing evidence-based practices to cultivate the next generation of respiratory care professionals. He exemplifies excellence in respiratory and critical care medicine, with a career characterized by impactful research, clinical leadership, and an enduring commitment to improving patient outcomes.


✨CONCLUSION:

Dr. Na Wang stands as a beacon of excellence in Respiratory and Critical Care Medicine, particularly in the management and research of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Her journey from a dedicated academic to an influential clinician and researcher reflects her unwavering commitment to advancing healthcare. Through groundbreaking research, impactful teaching, and exemplary clinical practice, Dr. Wang has significantly shaped the field, improving the lives of countless patients and setting a high standard for future contributions.

📊🔬NOTABLE PUBLICATION:
  • The association between chronic obstructive pulmonary disease and autoimmune diseases: a bidirectional Mendelian randomization study
    • Authors: Yu, X., Cheng, X., Lv, L., … Hu, T., Shi, Z.
    • Journal: Frontiers in Medicine
    • Year: 2024

  • A left pulmonary artery sling with left bronchiectasis in an adult patient: A case report and review of literature
    • Authors: Lv, L., Cheng, X., Yu, X., … Liu, J., Shi, Z.
    • Journal: Respirology Case Reports
    • Year: 2023

  • Prolonged elevated heart rate is associated with adverse outcome in severe pulmonary embolism: A retrospective study
    • Authors: Wang, G., Liu, T., Ji, W., … Hu, T., Shi, Z.
    • Journal: International Journal of Cardiology
    • Year: 2024

  • Association between prognostic nutritional index and mortality risk in patients with community-acquired pneumonia: a retrospective study
    • Authors: Wang, G., Wang, N., Liu, T., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024

  • Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients
    • Authors: Wang, N., Li, M., Wang, G., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

Assoc Prof Dr. Elcin Aydin | Endometrium Cancer | Best Researcher Award

University of Health Sciences, Izmir | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

  • Assoc Prof Dr. Elçin Aydın’s academic journey began with a strong foundation in medical sciences. She pursued her education with a focus on radiology, demonstrating a keen interest in the diagnostic and therapeutic applications of imaging technologies. Her early academic pursuits laid the groundwork for her specialization in abdominal and genitourinary radiology.

PROFESSIONAL ENDEAVORS

  • Dr. Aydın is currently affiliated with the University of Health Sciences in Izmir, Turkey, and works at Izmir City Hospital. Her professional endeavors have been marked by a commitment to clinical excellence and academic rigor. She has been an active member of prestigious organizations such as the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Congress of Radiology (ECR), and the European Society of Urogenital Radiology (ESUR).

CONTRIBUTIONS AND RESEARCH FOCUS

  • Dr. Aydın has made significant contributions to the field of radiology through her research and clinical work. She has published 14 original articles in SCI-EXP indexed journals and authored 4 case studies, highlighting her expertise in abdominal and genitourinary radiology. Her research focuses on the diagnostic accuracy and clinical applications of imaging techniques in these areas, aiming to improve patient outcomes through advanced radiological practices.

IMPACT AND INFLUENCE

  • Through her scholarly publications and clinical practice, Dr. Aydın has had a considerable impact on the field of radiology. Her work is frequently cited by peers, reflecting the influence of her research on contemporary radiological practices. Her involvement in ESGAR, ECR, and ESUR underscores her influence within the radiological community, where she contributes to the advancement of knowledge and practice standards.

ACADEMIC CITATIONS

  • Dr. Aydın’s research has garnered significant academic attention, with numerous citations in prominent radiological journals. Her studies on abdominal and genitourinary radiology are referenced by other researchers and clinicians, indicating the high regard in which her work is held. This academic recognition is a testament to the quality and relevance of her research contributions.

LEGACY AND FUTURE CONTRIBUTIONS ON ENDOMETRIUM CANCER

  • Dr. Aydın’s legacy in the field of radiology is characterized by her dedication to advancing medical imaging and improving patient care. Looking ahead, she is poised to continue her impactful research and clinical work, with a focus on innovative imaging techniques and their applications in abdominal and genitourinary radiology. Her future contributions are expected to further enhance the understanding and practice of radiology, benefiting both the medical community and patients.

OTHER IMPORTANT TOPICS

TEACHING AND MENTORSHIP

  • In addition to her research and clinical responsibilities, Dr. Aydın is deeply committed to teaching and mentoring the next generation of radiologists. Her role at the University of Health Sciences allows her to shape the education and training of medical students and residents, ensuring the continued growth and development of the field.

COLLABORATIVE PROJECTS

  • Dr. Aydın actively engages in collaborative projects with other institutions and researchers. These collaborations enable the sharing of knowledge and expertise, fostering innovation and improving radiological practices globally. Her collaborative efforts have resulted in several joint publications and research initiatives.

PROFESSIONAL DEVELOPMENT

  • Continuous professional development is a cornerstone of Dr. Aydın’s career. She regularly participates in international conferences, workshops, and training programs to stay abreast of the latest advancements in radiology. This commitment to lifelong learning ensures that she remains at the forefront of her field, providing the highest standard of care to her patients.

 

📊🔬Notable Publication:

Extrapulmonary Tuberculosis: An Old but Resurgent Problem

  • Authors: Baykan, A.H., Sayiner, H.S., Aydin, E., Inan, I., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2022

 

Quantitative Analysis of the Olfactory System in COVID-19: An MR Imaging Study

  • Authors: Altunisik, E., Baykan, A.H., Sahin, S., Aydin, E., Erturk, S.M.
    Journal: American Journal of Neuroradiology
  • Year: 2021

 

Primary Breast Tuberculosis: Imaging Findings of a Rare Disease

  • Authors: Baykan, A.H., Sayiner, H.S., Inan, I., Aydin, E., Erturk, S.M.
    Journal: Insights into Imaging
  • Year: 2021

 

Reliability of Real-Time Sonoelastography in the Diagnosis of Supraspinatus Tendinopathy

  • Authors: Aydın, E., Söylev, G.Ö., Muratlı, S.K., Tekindal, M.A., Ağıldere, M.
    Journal: Ultrasound Quarterly
  • Year: 2021

 

Optical Coherence Tomography-Angiography Findings of Prediabetic Patients

  • Authors: Emre, S., Altin, C., Ulusoy, M.O., Aydin, E.
    Journal: Oman Journal of Ophthalmology
  • Year: 2024

Ms. Hao Li – Tumor Immunology – Young Scientist Award

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)

 

Dr. Francesco Raspagliesi – Gynecologic Oncology – Best Researcher Award

Dr. Francesco Raspagliesi - Gynecologic Oncology - Best Researcher Award

Fondazione IRCCS Istituto nazionale Tumori di Milano - Italy  

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Francesco Raspagliesi began his academic journey with a Degree in Medicine and Surgery from the University of Catania, Italy, which he completed on March 7, 1981. Following this foundational education, he obtained qualifications to practice medicine in 1981 and specialized in Obstetrics and Gynecology from the University of Catania in 1985 and 1988. These early academic pursuits laid the groundwork for his future professional endeavors in the field of gynecologic oncology.

PROFESSIONAL ENDEAVORS

From 1985 to 1992, Raspagliesi served as a Research Fellow at the Fondazione IRCCS Istituto Nazionale Tumori di Milano. He continued his professional growth at the same institution, becoming a Dirigente Medico di 1° Livello from 1992 to 1999 and advancing to Dirigente Medico di 2° Livello Gynecologic Oncology Unit Director from 1999 to 2019. His long-standing association with the Fondazione IRCCS Istituto Nazionale Tumori di Milano demonstrates his commitment and dedication to the field of gynecologic oncology and patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON GYNECOLOGIC ONCOLOGY

Throughout his career, Raspagliesi has made significant contributions to the field of Obstetrics and Gynecology. His research and clinical work have focused on gynecologic oncology, particularly in the treatment and management of gynecologic cancers. His expertise and leadership as the Gynecologic Oncology Unit Director have contributed to advancements in the diagnosis, treatment, and care of patients with gynecologic cancers.

IMPACT AND INFLUENCE

As a respected figure in the field of gynecologic oncology, Raspagliesi's work has had a profound impact on patient care, research, and education. His leadership roles and contributions to research have helped shape the way gynecologic cancers are treated and managed, influencing clinical practice and improving patient outcomes.

LEGACY AND FUTURE CONTRIBUTIONS

Francesco Raspagliesi's legacy in the field of Obstetrics and Gynecology is characterized by his dedication to patient care, leadership in gynecologic oncology, and contributions to research and education. His continued commitment to advancing the field through research, mentorship, and clinical practice ensures that his influence will be felt by future generations of gynecologic oncologists.

NOTABLE PUBLICATIONS

Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.  2024

Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes. 2024

Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.  2024

Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens. 2024

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics? (2) 2024